Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting
about
Lentiviral vectors to probe and manipulate the Wnt signaling pathwayInvolvement of crosstalk between Oct4 and Meis1a in neural cell fate decision.Evidence for tankyrases as antineoplastic targets in lung cancer.Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypesTankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle studyHeadway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference.All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patchedCanonical and noncanonical Wnt signaling in neural stem/progenitor cells.Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.Crosstalk between SOXB1 proteins and WNT/β-catenin signaling in NT2/D1 cells.Quantitative and kinetic profile of Wnt/β-catenin signaling components during human neural progenitor cell differentiation.Distinct roles for Wnt-4 and Wnt-11 during retinoic acid-induced neuronal differentiation.Adult Mouse Liver Contains Two Distinct Populations of Cholangiocytes.Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis.Inhibitory effects of XAV939 on the proliferation of small-cell lung cancer H446 cells and Wnt/β-catenin signaling pathway in vitro.
P2860
Q28472995-246AC8EA-4C34-4795-89A8-096BA0543B42Q34602889-087D65FF-0260-4DAC-8C36-0ECFF088D82EQ34690600-94EF534E-1823-4178-B701-1DA8635CD26BQ35407771-1BF59CA8-D9D1-4237-ABA5-A68D4203FA00Q36261420-5F2683B0-09C2-4F7B-8163-146DC26A7BC4Q37601036-0BFB7980-4E70-4C79-A257-D2D73A743AA5Q37690746-5AC9E0B6-D055-4332-9E4E-61491E13930DQ37692468-A30D25F7-61FB-49D4-AAF1-88F987ABEBFCQ38573790-D5395AED-F767-47FB-B357-C38C01F858ECQ38717343-F27D0855-3228-4824-AA37-F019D7A408ABQ38977947-4D531485-F656-4D92-8A32-3A801267D9FEQ39497356-1B96E397-6E1A-413E-BF44-D43944A0092AQ39600411-CB7AB9A5-6733-441B-A105-58CD1CE9E2D9Q41324865-7807B573-ADEC-4EB1-8ED1-8DEBB467DFA6Q48533288-57C55C6B-B94B-4D79-939C-D0A4C598271EQ55643844-956B302A-7137-4EF3-A813-645D5AF670D5
P2860
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@ast
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@en
Wnt pathway reprogramming duri ...... ial for therapeutic targeting.
@nl
type
label
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@ast
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@en
Wnt pathway reprogramming duri ...... ial for therapeutic targeting.
@nl
prefLabel
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@ast
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@en
Wnt pathway reprogramming duri ...... ial for therapeutic targeting.
@nl
P2093
P2860
P356
P1433
P1476
Wnt pathway reprogramming duri ...... tial for therapeutic targeting
@en
P2093
Alexander M Busch
Allison C Kasper
Elisabeth Schwarz
Ethan Dmitrovsky
Grace E Snow
Katherine E Ewings
Michael J Spinella
Sarah J Freemantle
Thomas Bee
P2860
P2888
P356
10.1186/1471-2407-9-383
P407
P577
2009-10-29T00:00:00Z
P5875
P6179
1007466599